| William A Houser, MD | |
|
2220 Timber Trl, Bellefontaine, OH 43311-9039 | |
| (937) 599-6105 | |
| (937) 599-7500 |
| Full Name | William A Houser |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 34 Years |
| Location | 2220 Timber Trl, Bellefontaine, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801804372 | NPI | - | NPPES |
| 0242946 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 35065673 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Rutan Hospital | Bellefontaine, OH | Hospital |
| Memorial Hospital | Marysville, OH | Hospital |
| Hardin Memorial Hospital | Kenton, OH | Hospital |
| Ohio State University State Health System | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Internal Medicine Llc | 5496651408 | 984 |
| Mary Rutan Hospital | 9032013792 | 77 |
News Archive
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
St. Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function.
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Entity Name | Mary Rutan Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548254931 PECOS PAC ID: 9032013792 Enrollment ID: O20031124000531 |
News Archive
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
St. Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function.
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Entity Name | Osu Internal Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740231448 PECOS PAC ID: 5496651408 Enrollment ID: O20031210000658 |
News Archive
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
St. Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function.
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William A Houser, MD 700 Ackerman Rd Ste 2120, Columbus, OH 43202-1559 Ph: (614) 293-2594 | William A Houser, MD 2220 Timber Trl, Bellefontaine, OH 43311-9039 Ph: (937) 599-6105 |
News Archive
The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other heart failure devices, such as cardiac resynchronization therapy.
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
A plaster which sticks to the inside of your mouth is revolutionising the treatment of painful recurring ulcers.
St. Jude Children's Research Hospital investigators have gained new insight into how the cell's vast array of proteins would instantly be reduced to a confusion of lethally malfunctioning molecules without a system for proteins to "accessorize" in order to regulate their function.
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed against the MAGE-A4 cancer antigen, achieved responses in patients with multiple solid tumor types, including synovial sarcoma, head and neck cancer and lung cancer, according to results from a Phase I clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
Winfred E Stoltzfus, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2231 Timber Trl, Bellefontaine, OH 43311 Phone: 937-599-3115 | |
Grant K Varian, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 205 E Palmer Rd, Bellefontaine, OH 43311 Phone: 937-592-4015 | |
Gregg S Fulmer, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 205 Palmer Ave., Bellefontaine, OH 43311 Phone: 937-592-4015 | |
Sami Mahmoud Aasar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 205 E Palmer Rd, Bellefontaine, OH 43311 Phone: 937-592-9221 | |
Dr. Indrani Shreekanth Chutkay, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2231 Timber Trl, Bellefontaine, OH 43311 Phone: 937-599-3115 |